29681796|t|Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
29681796|a|N-methyl-D-aspartate receptors (NMDARs), glutamate-gated ion channels, mediate signaling at the majority of excitatory synapses in the nervous system. Recent sequencing data for neurological and psychiatric patients have indicated numerous mutations in genes encoding for NMDAR subunits. Here, we present surface expression, functional, and pharmacological analysis of 11 de novo missense mutations of the human hGluN2B subunit (P553L; V558I; W607C; N615I; V618G; S628F; E657G; G820E; G820A; M824R; L825V) located in the pre-M1, M1, M2, M3, and M4 membrane regions. These variants were identified in patients with intellectual disability, developmental delay, epileptic symptomatology, and autism spectrum disorder. Immunofluorescence microscopy indicated that the ratio of surface-to-total NMDAR expression was reduced for hGluN1/hGluN2B(S628F) receptors and increased for for hGluN1/hGluN2B(G820E) receptors. Electrophysiological recordings revealed that agonist potency was altered in hGluN1/hGluN2B(W607C; N615I; and E657G) receptors and desensitization was increased in hGluN1/hGluN2B(V558I) receptors. The probability of channel opening of hGluN1/hGluN2B (V558I; W607C; V618G; and L825V) receptors was diminished ~10-fold when compared to non-mutated receptors. Finally, the sensitivity of mutant receptors to positive allosteric modulators of the steroid origin showed that glutamate responses induced in hGluN1/hGluN2B(V558I; W607C; V618G; and G820A) receptors were potentiated by 59-96% and 406-685% when recorded in the presence of 20-oxo-pregn-5-en-3beta-yl sulfate (PE-S) and androst-5-en-3beta-yl hemisuccinate (AND-hSuc), respectively. Surprisingly hGluN1/hGluN2B(L825V) receptors were strongly potentiated, by 197 and 1647%, respectively, by PE-S and AND-hSuc. Synaptic-like responses induced by brief glutamate application were also potentiated and the deactivation decelerated. Further, we have used homology modeling based on the available crystal structures of GluN1/GluN2B NMDA receptor followed by molecular dynamics simulations to try to relate the functional consequences of mutations to structural changes. Overall, these data suggest that de novo missense mutations of the hGluN2B subunit located in membrane domains lead to multiple defects that manifest by the NMDAR loss of function that can be rectified by steroids. Our results provide an opportunity for the development of new therapeutic neurosteroid-based ligands to treat diseases associated with hypofunction of the glutamatergic system.
29681796	109	114	Human	Species	9606
29681796	115	121	GluN2B	Gene	2904
29681796	172	181	glutamate	Chemical	MESH:D018698
29681796	326	337	psychiatric	Disease	MESH:D001523
29681796	338	346	patients	Species	9606
29681796	537	542	human	Species	9606
29681796	560	565	P553L	ProteinMutation	tmVar:p|SUB|P|553|L;HGVS:p.P553L;VariantGroup:1;CorrespondingGene:2904;RS#:397514556(Expired);CorrespondingSpecies:9606;CA#:130440
29681796	567	572	V558I	ProteinMutation	tmVar:p|SUB|V|558|I;HGVS:p.V558I;VariantGroup:6;CorrespondingGene:2904;RS#:1057519004;CorrespondingSpecies:9606
29681796	574	579	W607C	ProteinMutation	tmVar:p|SUB|W|607|C;HGVS:p.W607C;VariantGroup:5;CorrespondingGene:2904;RS#:1057518700;CorrespondingSpecies:9606
29681796	581	586	N615I	ProteinMutation	tmVar:p|SUB|N|615|I;HGVS:p.N615I;VariantGroup:2;CorrespondingGene:2904;RS#:672601377;CorrespondingSpecies:9606;CA#:174969
29681796	588	593	V618G	ProteinMutation	tmVar:p|SUB|V|618|G;HGVS:p.V618G;VariantGroup:3;CorrespondingGene:2904;RS#:672601376;CorrespondingSpecies:9606;CA#:174968
29681796	595	600	S628F	ProteinMutation	tmVar:p|SUB|S|628|F;HGVS:p.S628F;VariantGroup:7;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	602	607	E657G	ProteinMutation	tmVar:p|SUB|E|657|G;HGVS:p.E657G;VariantGroup:0;CorrespondingGene:2904;RS#:876661041;CorrespondingSpecies:9606;CA#:10577449
29681796	609	614	G820E	ProteinMutation	tmVar:p|SUB|G|820|E;HGVS:p.G820E;VariantGroup:4;CorrespondingGene:2904;RS#:797044849;CorrespondingSpecies:9606
29681796	616	621	G820A	ProteinMutation	tmVar:p|SUB|G|820|A;HGVS:p.G820A;VariantGroup:4;CorrespondingGene:2904;RS#:797044849;CorrespondingSpecies:9606;CA#:204589
29681796	623	628	M824R	ProteinMutation	tmVar:p|SUB|M|824|R;HGVS:p.M824R;VariantGroup:9;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	630	635	L825V	ProteinMutation	tmVar:p|SUB|L|825|V;HGVS:p.L825V;VariantGroup:8;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	731	739	patients	Species	9606
29681796	745	768	intellectual disability	Disease	MESH:D008607
29681796	770	789	developmental delay	Disease	MESH:D002658
29681796	791	815	epileptic symptomatology	Disease	MESH:D004827
29681796	821	845	autism spectrum disorder	Disease	MESH:D000067877
29681796	970	975	S628F	ProteinMutation	tmVar:p|SUB|S|628|F;HGVS:p.S628F;VariantGroup:7;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	1024	1029	G820E	ProteinMutation	tmVar:p|SUB|G|820|E;HGVS:p.G820E;VariantGroup:4;CorrespondingGene:2904;RS#:797044849;CorrespondingSpecies:9606
29681796	1134	1139	W607C	ProteinMutation	tmVar:p|SUB|W|607|C;HGVS:p.W607C;VariantGroup:5;CorrespondingGene:2904;RS#:1057518700;CorrespondingSpecies:9606
29681796	1141	1146	N615I	ProteinMutation	tmVar:p|SUB|N|615|I;HGVS:p.N615I;VariantGroup:2;CorrespondingGene:2904;RS#:672601377;CorrespondingSpecies:9606;CA#:174969
29681796	1152	1157	E657G	ProteinMutation	tmVar:p|SUB|E|657|G;HGVS:p.E657G;VariantGroup:0;CorrespondingGene:2904;RS#:876661041;CorrespondingSpecies:9606;CA#:10577449
29681796	1221	1226	V558I	ProteinMutation	tmVar:p|SUB|V|558|I;HGVS:p.V558I;VariantGroup:6;CorrespondingGene:2904;RS#:1057519004;CorrespondingSpecies:9606
29681796	1293	1298	V558I	ProteinMutation	tmVar:p|SUB|V|558|I;HGVS:p.V558I;VariantGroup:6;CorrespondingGene:2904;RS#:1057519004;CorrespondingSpecies:9606
29681796	1300	1305	W607C	ProteinMutation	tmVar:p|SUB|W|607|C;HGVS:p.W607C;VariantGroup:5;CorrespondingGene:2904;RS#:1057518700;CorrespondingSpecies:9606
29681796	1307	1312	V618G	ProteinMutation	tmVar:p|SUB|V|618|G;HGVS:p.V618G;VariantGroup:3;CorrespondingGene:2904;RS#:672601376;CorrespondingSpecies:9606;CA#:174968
29681796	1318	1323	L825V	ProteinMutation	tmVar:p|SUB|L|825|V;HGVS:p.L825V;VariantGroup:8;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	1485	1492	steroid	Chemical	MESH:D013256
29681796	1512	1521	glutamate	Chemical	MESH:D018698
29681796	1558	1563	V558I	ProteinMutation	tmVar:p|SUB|V|558|I;HGVS:p.V558I;VariantGroup:6;CorrespondingGene:2904;RS#:1057519004;CorrespondingSpecies:9606
29681796	1565	1570	W607C	ProteinMutation	tmVar:p|SUB|W|607|C;HGVS:p.W607C;VariantGroup:5;CorrespondingGene:2904;RS#:1057518700;CorrespondingSpecies:9606
29681796	1572	1577	V618G	ProteinMutation	tmVar:p|SUB|V|618|G;HGVS:p.V618G;VariantGroup:3;CorrespondingGene:2904;RS#:672601376;CorrespondingSpecies:9606;CA#:174968
29681796	1583	1588	G820A	ProteinMutation	tmVar:p|SUB|G|820|A;HGVS:p.G820A;VariantGroup:4;CorrespondingGene:2904;RS#:797044849;CorrespondingSpecies:9606;CA#:204589
29681796	1673	1707	20-oxo-pregn-5-en-3beta-yl sulfate	Chemical	-
29681796	1709	1713	PE-S	Chemical	-
29681796	1719	1754	androst-5-en-3beta-yl hemisuccinate	Chemical	-
29681796	1756	1764	AND-hSuc	Chemical	-
29681796	1809	1814	L825V	ProteinMutation	tmVar:p|SUB|L|825|V;HGVS:p.L825V;VariantGroup:8;CorrespondingGene:2904;CorrespondingSpecies:9606
29681796	1888	1892	PE-S	Chemical	-
29681796	1897	1905	AND-hSuc	Chemical	-
29681796	1948	1957	glutamate	Chemical	MESH:D018698
29681796	2111	2116	GluN1	Gene	2902
29681796	2117	2123	GluN2B	Gene	2904
29681796	2467	2475	steroids	Chemical	MESH:D013256
29681796	2612	2627	hypofunction of	Disease	MESH:D000309
29681796	2632	2652	glutamatergic system	Disease	MESH:D015619
29681796	Association	MESH:D002658	RS#:876661041;HGVS:p.E657G;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:876661041;HGVS:p.E657G;CorrespondingGene:2904
29681796	Association	MESH:D015619	RS#:1057519004;HGVS:p.V558I;CorrespondingGene:2904
29681796	Association	MESH:D004827	HGVS:p.M824R;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:876661041;HGVS:p.E657G;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:876661041;HGVS:p.E657G;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:672601376;HGVS:p.V618G;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:797044849;HGVS:p.G820E;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:1057518700;HGVS:p.W607C;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:672601377;HGVS:p.N615I;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:1057518700;HGVS:p.W607C;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:797044849;HGVS:p.G820A;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:1057518700;HGVS:p.W607C;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:1057519004;HGVS:p.V558I;CorrespondingGene:2904
29681796	Association	MESH:D018698	RS#:797044849;HGVS:p.G820A;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:397514556(Expired);HGVS:p.P553L;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:672601376;HGVS:p.V618G;CorrespondingGene:2904
29681796	Association	MESH:D000067877	HGVS:p.M824R;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:1057518700;HGVS:p.W607C;CorrespondingGene:2904
29681796	Association	MESH:D000067877	HGVS:p.L825V;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:1057519004;HGVS:p.V558I;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:397514556(Expired);HGVS:p.P553L;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:1057519004;HGVS:p.V558I;CorrespondingGene:2904
29681796	Association	MESH:D002658	HGVS:p.M824R;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:1057519004;HGVS:p.V558I;CorrespondingGene:2904
29681796	Association	MESH:D002658	HGVS:p.L825V;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:397514556(Expired);HGVS:p.P553L;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:797044849;HGVS:p.G820A;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:672601377;HGVS:p.N615I;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:672601377;HGVS:p.N615I;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:672601377;HGVS:p.N615I;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:797044849;HGVS:p.G820E;CorrespondingGene:2904
29681796	Association	MESH:D008607	HGVS:p.L825V;CorrespondingGene:2904
29681796	Association	MESH:D008607	HGVS:p.S628F;CorrespondingGene:2904
29681796	Association	MESH:D000067877	HGVS:p.S628F;CorrespondingGene:2904
29681796	Association	MESH:D000309	2902
29681796	Association	MESH:D015619	2902
29681796	Association	MESH:D008607	HGVS:p.M824R;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:672601376;HGVS:p.V618G;CorrespondingGene:2904
29681796	Association	MESH:D004827	RS#:797044849;HGVS:p.G820A;CorrespondingGene:2904
29681796	Association	MESH:D008607	RS#:797044849;HGVS:p.G820E;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:397514556(Expired);HGVS:p.P553L;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:672601376;HGVS:p.V618G;CorrespondingGene:2904
29681796	Association	MESH:D002658	RS#:797044849;HGVS:p.G820E;CorrespondingGene:2904
29681796	Association	MESH:D000067877	RS#:797044849;HGVS:p.G820A;CorrespondingGene:2904
29681796	Association	MESH:D004827	HGVS:p.L825V;CorrespondingGene:2904
29681796	Association	MESH:D004827	HGVS:p.S628F;CorrespondingGene:2904
29681796	Association	MESH:D002658	2904
29681796	Association	MESH:D004827	2904
29681796	Association	MESH:D015619	2904
29681796	Association	MESH:D000067877	2904
29681796	Association	MESH:D008607	2904

